Saad Z. Usmani, MD, FACP, discusses the potential utility of allogeneic CAR T-cell therapy in multiple myeloma.
Saad Z. Usmani, MD, Atrium Health
Advertisement
Articles by Saad Z. Usmani, MD, Atrium Health
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Krystal Biotech’s Neurotrophic Keratitis Gene Therapy Viral Vector Secures FDA Platform Technology Designation
2
FDA Picks Abeona’s XLRS Gene Therapy ABO-503 for RDEA Pilot Program
3
Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025
4
Tr1X's Multiple Sclerosis Cell Therapy TRX319 Cleared for US Trial
5
